Curable.'s latest marketcap:
As of 08/14/2025, Curable.'s market capitalization has reached $3.08 M. According to our data, Curable. is the 45746th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.08 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 146,970 |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Curable.'s yearly market capitalization.
| Date | Market Cap(₩) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/14/2025 | ₩4.27 B | $3.08 M | -99.17% | 45746 |
| 12/30/2024 | ₩7.04 B | $4.72 M | -63.55% | 41069 |
| 12/28/2023 | ₩19.31 B | $14.87 M | -0.68% | 35272 |
| 12/29/2022 | ₩19.44 B | $15.36 M | 93.49% | 34010 |
| 12/29/2021 | ₩10.05 B | $8.44 M | 25.09% | 36065 |
| 12/30/2020 | ₩8.03 B | $7.39 M | 52.42% | 33019 |
| 12/30/2019 | ₩5.27 B | $4.53 M | -60.3% | 30926 |
| 12/28/2018 | ₩13.28 B | $11.82 M | 23.39% | 27326 |
| 12/28/2017 | ₩10.76 B | $10.01 M | 27632 |
Company Profile
About Curable Inc.
Curable Inc. is a South Korea-based company specializing in single nucleotide polymorphism (SNP) research and analysis. Formerly known as SNP Genetics Inc., the company has been serving the biotech and pharmaceutical industries since its founding in 2000.
Services Offered
- Genome Analysis: Comprehensive sequencing and re-sequencing services.
- Immunoprecipitate Sequencing: Advanced techniques for targeted DNA analysis.
- Small RNA Discovery & Analysis: Identification and profiling of small RNA molecules.
- Digital Gene Expression Profiling: High-throughput gene expression analysis.
- SNP Genotyping & Discovery: Customized SNP identification and genotyping solutions.
- Microsatellites Typing & DNA Sequencing: Precise genetic marker analysis.
- Bioinformatics & Statistical Analysis: Data interpretation and gene identification support.
Key Clients
The company primarily serves pharmaceutical companies, providing critical genetic research tools and insights.
Location
Curable Inc. is headquartered in Hwaseong-si, South Korea.
Frequently Asked Questions
-
What is Curable.'s (XKON-086460) current market cap?As of 08/14/2025, Curable. (including the parent company, if applicable) has an estimated market capitalization of $3.08 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Curable. (XKON-086460) rank globally by market cap?Curable. global market capitalization ranking is approximately 45746 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.